Prostate Cancer - Results from #2420

Prognostic impact of palpable prostate tumors on disease progression after robot-assisted radical prostatectomy: a single-center experience. July 26, 2023

Changes in Prostate-specific Antigen Screening after the 2018 United States Preventive Services Task Force Recommendations and Through the COVID-19 Pandemic. July 26, 2023

Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes. July 26, 2023

Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer. July 26, 2023

Prostate Cancer: Under-representation of African American men in research studies used in the latest NCCN guidelines. July 26, 2023

DNA Ploidy as a Potential Adjunct Prognostic Marker of Low-Risk Prostate Cancer Progression after Radical Prostatectomy. July 25, 2023

Acute toxicity comparison of magnetic resonance-guided adaptive versus fiducial or computed tomography-guided non-adaptive prostate stereotactic body radiotherapy: A systematic review and meta-analysis. July 25, 2023

Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial. July 25, 2023

Robotic simple prostatectomy vs HOLEP, a 'multi single-center' experiences comparison. July 25, 2023

The association of the type and number of D'Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancer. July 25, 2023

Financial burden of men with localized prostate cancer: a process paper. July 24, 2023

Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients. July 24, 2023

Unique spectrum of activating BRAF alterations in prostate cancer. July 24, 2023

Sociocultural factors associated with physical activity in Black prostate cancer survivors. July 24, 2023

Engagement with a local African-Caribbean community to explore perspectives and research priorities among Black men for prostate cancer using a co-participatory approach. July 24, 2023

Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen? July 23, 2023

Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer. July 21, 2023

Concept Mapping with Black Men: Barriers to Prostate Cancer Screening and Solutions. July 21, 2023

A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer. July 21, 2023

National Trends in Management of Newly Diagnosed Prostate Cancer. July 21, 2023

Page 122 of 1439